These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 17571369

  • 1. [ARB: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].
    Mitsuyama S.
    Nihon Rinsho; 2007 May 28; 65 Suppl 5():78-83. PubMed ID: 17571369
    [No Abstract] [Full Text] [Related]

  • 2. [Dosage equivalents of AT1-receptor antagonists available in Germany].
    Dominiak P, Häuser W.
    Dtsch Med Wochenschr; 2003 Oct 31; 128(44):2315-8. PubMed ID: 14593575
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of angiotensin II receptor blockers in the dog following a single oral administration.
    Baek IH, Lee BY, Lee ES, Kwon KI.
    Drug Res (Stuttg); 2013 Jul 31; 63(7):357-61. PubMed ID: 23539423
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Integrating drug pharmacokinetics for phenotyping individual renin response to angiotensin II blockade in humans.
    Azizi M, Bissery A, Lamarre-Cliche M, Ménard J.
    Hypertension; 2004 Apr 31; 43(4):785-90. PubMed ID: 15023936
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacological and clinical properties of ECARD combination tablets LD & HD, fixed-dose combination of candesartan cilexetil and hydrochlorothiazide].
    Kusumoto K, Mori M, Tanokashira J, Totsuka N.
    Nihon Yakurigaku Zasshi; 2009 Oct 31; 134(4):217-24. PubMed ID: 19828927
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
    Culman J, Jacob T, Schuster SO, Brolund-Spaether K, Brolund L, Cascorbi I, Zhao Y, Gohlke P.
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep 31; 390(9):949-959. PubMed ID: 28669009
    [Abstract] [Full Text] [Related]

  • 10. [Use of angiotensin II receptor blockaders in heart failure].
    Bonarjee VV, Dickstein K.
    Tidsskr Nor Laegeforen; 2000 Mar 10; 120(7):817-21. PubMed ID: 10806906
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Fast-acting sartan. High blood pressure therapy without long waiting time].
    MMW Fortschr Med; 2003 Jun 12; 145(24):55. PubMed ID: 12866306
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of antihypertensive treatment with angiotensin II receptor blockers on lipid profile: an open multi-drug comparison trial.
    Kyvelou SM, Vyssoulis GP, Karpanou EA, Adamopoulos DN, Zervoudaki AI, Pietri PG, Stefanadis CI.
    Hellenic J Cardiol; 2006 Jun 12; 47(1):21-8. PubMed ID: 16532712
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [AT-1 blockers are different in their effects. The forgetful patients begin to notice it especially].
    MMW Fortschr Med; 2003 Apr 10; 145(15):62. PubMed ID: 15104271
    [No Abstract] [Full Text] [Related]

  • 20. [Losartan].
    Pfaffendorf M.
    Dtsch Med Wochenschr; 1996 Sep 06; 121(36):1101-2. PubMed ID: 8846756
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.